Clinical Trials Directory

Trials / Completed

CompletedNCT05215210

The Effect of Long-term Momordica Charantia Supplementation on Blood Glucose Levels

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Wageningen University and Research · Academic / Other
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The study is a parallel, double blind, controlled trial in which study participants will receive a 12-week intervention with 3.6 g/d dried bitter-gourd supplements or a reference intervention with 3.6 g/d dried cucumber supplements. Research subjects will come to the research facility for a test day on four occasions, with an interval of 4 weeks. The main study parameter is fasting levels of plasma glucose.

Detailed description

Bitter gourd (BG) (Momordica charantia) is a highly nutritive vegetable from the cucumber family. The objective is to assess the impact of 12-weeks of BG supplementation on blood glucose levels in subjects with impaired fasting glucose levels. In a previous trial (Bitter-Zoet NL70259.081.19) the short-term effects of BG (4 weeks) were studied, but no effect was observed. In the current trial a different BG cultivar is chosen, the intervention period is prolonged, the dosage per day is higher and study subjects with slightly higher fasting blood glucose levels will be included. The study is a parallel, double blind, controlled trial in which study participants will receive a 12-week intervention with 3.6 g/d dried bitter-gourd supplements or a reference intervention with 3.6 g/d dried cucumber supplements. Research subjects will come to the research facility for a test day on four occasions, with an interval of 4 weeks. The main study parameter is fasting levels of plasma glucose. Secondary outcome measures are glucose tolerance, HbA1c, insulin and HOMA-IR and HOMA-B levels.

Conditions

Interventions

TypeNameDescription
OTHERBitter-gourd12-week intervention of 3.6 grams of dried bitter-gourd supplements
OTHERCucumber12-week intervention of 3.6 grams of cucumber supplements

Timeline

Start date
2022-03-23
Primary completion
2022-06-30
Completion
2022-06-30
First posted
2022-01-31
Last updated
2022-11-07

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05215210. Inclusion in this directory is not an endorsement.